ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Stock Price Down 5.2% – Should You Sell?

Shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) were down 5.2% during mid-day trading on Wednesday. The company traded as low as $10.06 and last traded at $10.07. 1,688 shares were traded during mid-day trading, a decline of 80% from the average session volume of 8,303 shares. The stock had previously closed at $10.62.

ProShares UltraShort Nasdaq Biotechnology Price Performance

The firm has a fifty day moving average of $11.36 and a 200 day moving average of $14.86.

About ProShares UltraShort Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

Recommended Stories

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.